MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-DL-10-0007454
Medtech Pharma (India) Private Limited
Medtech Pharma (India) Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹15.61 Cr
▲ 21% YoY
Net profit · FY 2025
₹27.19 Lakh
Net margin 1.7%
EBITDA · FY 2025
₹92.94 Lakh
EBITDA margin 6%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Open charges
₹5.43 Cr
Secured borrowings
Company age
28 yrs
Est. 1998
Directors on board
2
As per MCA filings
About Medtech Pharma (India) Private Limited
Data last updated:
Medtech Pharma (India) Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 17 March 1998 and has been in existence for over 28 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74900DL1998PTC092763. Its GSTIN is 07AACCM2553R1Z1 (Delhi).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Utpala and Lokesh Kumar Mehta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C – 46 Dgs Society Plot – 6 Dwarka Sector – 22, New Delhi, Delhi, India – 110075.
As per the financials filed for FY 2025, the company reported a revenue of ₹15.61 Cr, a growth of 21% compared to the previous year. For the same year it recorded a net profit of ₹27.19 Lakh (net margin 1.7%) and EBITDA of ₹92.94 Lakh (EBITDA margin 6%). Revenue has grown at a compounded annual rate (CAGR) of 15% over three years and 8% over five years.
As per MCA filings, the company has open charges of ₹5.43 Cr on record. Court records list 1 case involving the company, including 1 filed by the company.
Medtech Pharma (India) Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-10-0007454). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U74900DL1998PTC092763
Registration Number 092763
Incorporation Date 17 March 1998
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-DL-10-0007454
CIN history
Medtech Pharma (India) has one previous CIN (Corporate Identification Number): U99999DL1998PTC092763. The current CIN is U74900DL1998PTC092763, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U74900DL1998PTC092763 | Current |
| U99999DL1998PTC092763 | Previous |
Key People
Utpala Director Lokesh Kumar Mehta Director Recognitions & Rankings of Medtech Pharma (India)
Contact details
Medtech Pharma (India) Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressC – 46 Dgs Society Plot – 6 Dwarka Sector – 22, New Delhi, Delhi, India – 110075
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Medtech Pharma (India) Private Limited, buy the company report.
Comprehensive company report
Medtech Pharma (India) Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Medtech Pharma (India) is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Medtech Pharma (India) Private Limited, buy the company report.
Financials of Medtech Pharma (India) Private Limited
FY 2025 filings availableMedtech Pharma (India) Private Limited reported revenue of ₹15.61 Cr (up 21% YoY) for FY 2025.
Revenue · FY 2025
₹15.61 Cr ▲ 21%
Net profit · FY 2025
₹27.19 Lakh margin 1.7%
EBITDA · FY 2025
₹92.94 Lakh margin 6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 21%
3 years · compounded
▲ 15%
5 years · compounded
▲ 8%
EBITDA CAGR growth
1 year
▲ 12%
3 years · compounded
▲ 23%
5 years · compounded
▲ 4%
Revenue has grown at a compounded annual rate (CAGR) of 8% over five years, including 21% growth in the latest year. EBITDA rose 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹92.94 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹27.19 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6% | ||||
| Net Profit Margin | 1.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Medtech Pharma (India) Private Limited, buy the company report.
Board of directors of Medtech Pharma (India) Private Limited
Medtech Pharma (India) has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Utpala | Director | 01 Jun 2003 | 23 Years 4 Months | Current |
| Lokesh Kumar Mehta | Director | 01 Nov 2011 | 14 Years 11 Months | Current |
Peer comparison
Medtech Pharma (India) Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vetecura Life Sciences Private Limited | ₹15.71 Cr (FY 2025) | 52.0% | Ulhasnagar, Maharashtra, India | |||
| Leeford Medicare Limited | ₹15.69 Cr (FY 2025) | 11.0% | Ludhiana, Punjab, India | |||
| Farlex Pharmaceuticals Private Limited | ₹15.67 Cr (FY 2025) | 25.0% | Manimajra, Chandigarh, India | |||
| Medtech Pharma (India) Private Limitedthis company | ₹15.61 Cr (FY 2025) | ₹27.19 Lakh | 1.7% | 21.0% | New Delhi, Delhi, India | |
| Imperial Healthcare Private Limited | ₹15.55 Cr (FY 2025) | -3.0% | New Delhi, Delhi, India | |||
| Acuten Global Private Limited | ₹15.52 Cr (FY 2025) | 123.0% | Bangalore, Karnataka, India |
To see the full peer comparison of Medtech Pharma (India) Private Limited, buy the company report.
Auditor
Medtech Pharma (India) Private Limited is audited by RISHI KAPOOR AND COMPANY for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RISHI KAPOOR AND COMPANY | FY 2023 | 006615C |
Shareholding
The shareholding of Medtech Pharma (India) Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Medtech Pharma (India) Private Limited, buy the company report.
Charges & borrowings
Open charges
₹5.43 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 01 Aug 2025 | 101143795 | Others | ₹18 Lakh | Open | |
| 23 Sep 2020 | 100375149 | Others | ₹34.97 Lakh | Open | |
| 18 Jan 2019 | 100235919 | Others | ₹4.9 Cr | Open |
To see the full charge records of Medtech Pharma (India) Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
Medtech Pharma (India) Private Limited has 1 court case on record: 1 filed by Medtech Pharma (India). All case is disposed.
Total cases
1
Filed by the company
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Court case (CO.PET.) | Filed by the company against Registrar of Companies, New Delhi | Disposed |
To see the full case history of Medtech Pharma (India) Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medtech Pharma (India) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Medtech Pharma (India) has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AACCM2553R1Z1 | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Medtech Pharma (India) Private Limited, buy the company report.
Recent activity
Medtech Pharma (India) Private Limited has 4 board changes on record since 1998: 3 appointments and 1 cessation. The latest: Arvind Kumar ceased to be Director on 02 Dec 2011.
Charges
A charge with Others of Rs. 490.00 Lakh registered on 18 Jan 2019 with Charge ID 100235919 was modified on 14 Nov 2025.
AGM
Medtech Pharma (India) Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 18.00 Lakh with Charge ID 101143795 was registered on 01 Aug 2025.
Filing
Medtech Pharma (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge with Others amounted to Rs. 34.97 Lakh with Charge ID 100375149 was registered on 23 Sep 2020.
Charges
A charge with Others amounted to Rs. 490.00 Lakh with Charge ID 100235919 was registered on 18 Jan 2019.
Ceased
Arvind Kumar ceased to be Director.
Appointed
Lokesh Kumar Mehta was appointed as Director.
Appointed
Utpala was appointed as Director.
Appointed
Arvind Kumar was appointed as Director.
Incorporation
17 Mar 1998
Medtech Pharma (India) Private Limited was registered on 17 Mar 1998 with Roc Delhi & aged 28 years 7 months as per MCA records.
Frequently asked questions
Medtech Pharma (India) is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 17 March 1998 (28+ years old) and is registered under CIN U74900DL1998PTC092763.
Medtech Pharma (India) has 2 current directors:
- Utpala - Director
- Lokesh Kumar Mehta - Director
The latest financial statements of Medtech Pharma (India) on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Medtech Pharma (India) is 07AACCM2553R1Z1, registered in Delhi.
The CIN (Corporate Identification Number) of Medtech Pharma (India) is U74900DL1998PTC092763. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medtech Pharma (India) has 1 court case on record: 1 filed by the company.
Medtech Pharma (India) was incorporated on 17 March 1998, making it 28+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Medtech Pharma (India) by revenue are Vetecura Life Sciences Private Limited, Leeford Medicare Limited, Farlex Pharmaceuticals Private Limited, Imperial Healthcare Private Limited, Acuten Global Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Arvind Kumar ceased to be Director on 02 Dec 2011. Lokesh Kumar Mehta was appointed as Director on 01 Nov 2011. Utpala was appointed as Director on 01 Jun 2003. Medtech Pharma (India) has 4 board changes on record in total.
Yes, Medtech Pharma (India) is registered as a small enterprise under Udyam registration (number: UDYAM-DL-10-0007454).
The registered office of Medtech Pharma (India) is at C – 46 Dgs Society Plot – 6 Dwarka Sector – 22, New Delhi, Delhi, India – 110075.